Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Employee Health Care Protection Act of 2013
Client: EMD SERONO, INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act.H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Employee Health Care Protection Act of 2013
Client: EMD SERONO, INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act.H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ASTRAZENECA via EAST END GROUP, LLC
2013 · third_quarter · 3A
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACHAOGEN, INC via EAST END GROUP, LLC
2013 · third_quarter · 3@
Source: Senate LDA
| GLAXOSMITHKLINE |
| 14 |
| 2010–2013 |
| MEDIMMUNE | 14 | 2010–2013 |
| ACHAOGEN INC | 13 | 2011–2013 |
| ALERE INC. | 12 | 2011–2013 |
| NANOINK, INC. | 11 | 2010–2012 |
| EMD SERONO, INC. | 9 | 2012–2013 |
| PFENEX INC | 9 | 2011–2013 |
| CUBIST PHARMACEUTICALS, INC. | 8 | 2010–2012 |
| ASTELLAS PHARMA US, INC. | 6 | 2013 |
| PHARMATHENE, INC. | 6 | 2010–2011 |
| VARIAN MEDICAL SYSTEMS, INC. | 6 | 2011–2012 |
| EISAI, INC. | 5 | 2010–2011 |
| FOREST LABORATORIES INC | 5 | 2013 |
| GILEAD SCIENCES, INC. | 5 | 2012–2013 |
| EAST END GROUP, LLC | 3 | 2010 |
Employee Health Care Protection Act of 2013
Client: EMD SERONO, INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act.H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Employee Health Care Protection Act of 2013
Client: EMD SERONO, INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act.H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: ACHAOGEN, INC · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: ACHAOGEN, INC · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: ACHAOGEN, INC · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: ACHAOGEN, INC · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: MERCK & CO., INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: MERCK & CO., INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: MERCK & CO., INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: ACHAOGEN, INC · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: ACHAOGEN, INC · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: ACHAOGEN, INC · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: ACHAOGEN, INC · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act. H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act.H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act. H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act. H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Indonesian Family Refugee Protection Act
Client: MERCK & CO., INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: CUBIST PHARMACEUTICALS, INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; H.R. 6331, the Generating Antibiotic Incentives Now (GAIN) Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: CUBIST PHARMACEUTICALS, INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; H.R. 6331, the Generating Antibiotic Incentives Now (GAIN) Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: MERCK & CO., INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: MERCK & CO., INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: MERCK & CO., INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: MERCK & CO., INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues; and antimicrobial legislation and regulatory issues.
Indonesian Family Refugee Protection Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Indonesian Family Refugee Protection Act
Client: VARIAN MEDICAL SYSTEMS, INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for medical devices; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues for medical devices.
Indonesian Family Refugee Protection Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Generating Antibiotic Incentives Now Act of 2010
Client: CUBIST PHARMACEUTICALS, INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; H.R. 6331, the Generating Antibiotic Incentives Now (GAIN) Act; and the Food and Drugs Administration legislative and regulatory issues.
Generating Antibiotic Incentives Now Act of 2010
Client: CUBIST PHARMACEUTICALS, INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; H.R. 6331, the Generating Antibiotic Incentives Now (GAIN) Act; and the Food and Drugs Administration legislative and regulatory issues.
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via EAST END GROUP, LLC
2013 · third_quarter · 3@
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act.H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FOREST LABORATORIES, INC. via EAST END GROUP, LLC
2013 · third_quarter · 3@
General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTELLAS PHARMA US, INC. via EAST END GROUP, LLC
2013 · third_quarter · 3@
General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2013 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFENEX INC. via EAST END GROUP, LLC
2013 · third_quarter · Q3
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MERCK & CO., INC. via EAST END GROUP, LLC
2013 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE via EAST END GROUP, LLC
2013 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2013 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES INC via EAST END GROUP, LLC
2013 · third_quarter · Q3
Ryan White Care Act Reauthorization; Hepatitis C issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOREST LABORATORIES, INC. via EAST END GROUP, LLC
2013 · third_quarter · Q3
General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via EAST END GROUP, LLC
2013 · third_quarter · Q3
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act.H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via EAST END GROUP, LLC
2013 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2013 · third_quarter · Q3
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA via EAST END GROUP, LLC
2013 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTELLAS PHARMA US, INC. via EAST END GROUP, LLC
2013 · third_quarter · Q3
General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN, INC, via EAST END GROUP, LLC
2013 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALERE INC. via EAST END GROUP, LLC
2013 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACHAOGEN, INC via EAST END GROUP, LLC
2013 · third_quarter · Q3
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFENEX INC. via EAST END GROUP, LLC
2013 · second_quarter · Q2
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MERCK & CO., INC. via EAST END GROUP, LLC
2013 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE via EAST END GROUP, LLC
2013 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES INC via EAST END GROUP, LLC
2013 · second_quarter · Q2
Ryan White Care Act Reauthorization; Hepatitis C issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOREST LABORATORIES, INC. via EAST END GROUP, LLC
2013 · second_quarter · Q2
General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via EAST END GROUP, LLC
2013 · second_quarter · Q2
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act.H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via EAST END GROUP, LLC
2013 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2013 · second_quarter · Q2
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA via EAST END GROUP, LLC
2013 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTELLAS PHARMA US, INC. via EAST END GROUP, LLC
2013 · second_quarter · Q2
General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALERE INC. via EAST END GROUP, LLC
2013 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACHAOGEN, INC via EAST END GROUP, LLC
2013 · second_quarter · Q2
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2013 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN, INC, via EAST END GROUP, LLC
2013 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2013 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTELLAS PHARMA US, INC. via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FOREST LABORATORIES, INC. via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTELLAS PHARMA US, INC. via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FOREST LABORATORIES, INC. via EAST END GROUP, LLC
2013 · first_quarter · RR
Infectious disease product discovery, approval and payment.
Infectious disease product discovery, approval and payment.
ASTELLAS PHARMA US, INC. via EAST END GROUP, LLC
2013 · first_quarter · RR
Infectious disease product discovery, approval and payment.
Infectious disease product discovery, approval and payment.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES INC via EAST END GROUP, LLC
2013 · first_quarter · Q1
Ryan White Care Act Reauthorization; Hepatitis C issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFENEX INC. via EAST END GROUP, LLC
2013 · first_quarter · Q1
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MERCK & CO., INC. via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act.H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2013 · first_quarter · Q1
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN, INC, via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALERE INC. via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACHAOGEN, INC via EAST END GROUP, LLC
2013 · first_quarter · Q1
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MERCK & CO., INC. via EAST END GROUP, LLC
2012 · fourth_quarter · 4A
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues; and antimicrobial legislation and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MERCK & CO., INC. via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act.H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES INC via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
Ryan White Care Act Reauthorization; Hepatitis C issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC via EAST END GROUP, LLC
2012 · fourth_quarter · RR
Ryan White Care Act Reauthorization; Hepatitis C issues.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFENEX INC. via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN, INC, via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALERE INC. via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACHAOGEN, INC via EAST END GROUP, LLC
2012 · fourth_quarter · Q4
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NANOINK, INC. via EAST END GROUP, LLC
2012 · third_quarter · 3T
General issues related to drug safety and pharmaceutical security; and the Food and Drugs Administration legislative and regulatory issues related to drug safety.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NANOINK, INC. via EAST END GROUP, LLC
2012 · third_quarter · Q3
General issues related to drug safety and pharmaceutical security; and the Food and Drugs Administration legislative and regulatory issues related to drug safety.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2012 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFENEX INC. via EAST END GROUP, LLC
2012 · third_quarter · Q3
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MERCK & CO., INC. via EAST END GROUP, LLC
2012 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE via EAST END GROUP, LLC
2012 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2012 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via EAST END GROUP, LLC
2012 · third_quarter · Q3
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act. H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via EAST END GROUP, LLC
2012 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2012 · third_quarter · Q3
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA via EAST END GROUP, LLC
2012 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN, INC, via EAST END GROUP, LLC
2012 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALERE INC. via EAST END GROUP, LLC
2012 · third_quarter · Q3
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACHAOGEN, INC via EAST END GROUP, LLC
2012 · third_quarter · Q3
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2012 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFENEX INC. via EAST END GROUP, LLC
2012 · second_quarter · Q2
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NANOINK, INC. via EAST END GROUP, LLC
2012 · second_quarter · Q2
General issues related to drug safety and pharmaceutical security; and the Food and Drugs Administration legislative and regulatory issues related to drug safety.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO., INC. via EAST END GROUP, LLC
2012 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE via EAST END GROUP, LLC
2012 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2012 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via EAST END GROUP, LLC
2012 · second_quarter · Q2
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act. H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via EAST END GROUP, LLC
2012 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2012 · second_quarter · Q2
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA via EAST END GROUP, LLC
2012 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN, INC, via EAST END GROUP, LLC
2012 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALERE INC. via EAST END GROUP, LLC
2012 · second_quarter · Q2
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACHAOGEN, INC via EAST END GROUP, LLC
2012 · second_quarter · Q2
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFENEX INC. via EAST END GROUP, LLC
2012 · first_quarter · Q1
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via EAST END GROUP, LLC
2012 · first_quarter · Q1
General health care coverage and reimbursement; the Food and Drugs Administration legislative and regulatory issues; H.R. 3522, The Family Act. H.R. 3522, The Family Act and tax issues related to credits for certain health care treatments.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via EAST END GROUP, LLC
2012 · first_quarter · RR
Tax issues, Food and Drug regulation, and public health issues.
Tax issues, Food and Drug regulation, and public health issues.
Tax issues, Food and Drug regulation, and public health issues.
VARIAN MEDICAL SYSTEMS, INC. via EAST END GROUP, LLC
2012 · first_quarter · 1T
General health care coverage and reimbursement for medical devices; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues for medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CUBIST PHARMACEUTICALS, INC. via EAST END GROUP, LLC
2012 · first_quarter · 1T
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; H.R. 6331, the Generating Antibiotic Incentives Now (GAIN) Act; and the Food and Drugs Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE